The New Zealand General Practice Podcast

Dr Dave updates Dr Jo about abnormal uterine bleeding, and they talk about Rosuvastatin, Thyrotoxic Periodic Paralysis & Prednisone, ADHD meds and ocular adverse effects. Dr Jo misunderstands Alpha-gal syndrome, Dave saves the day by talking about the Arms Act 2026. There are quick IMAC updates, an ACC sensitive claims resource, Sepsis cards and they chat about, Private bowel screening, Ivermectin cream for rosacea and finally start preparing for the holidays with a few novel suggestions.

Dr Dave teaches Dr Jo about exploding head syndrome, alcohol harms, migraine treatments, ACC and Diabetes changes and how to stop antidepressants amongst other things. The shownotes can be found at https://opotikigp.com/

This month Dr Dave teaches Dr Jo about.. Peptides, Methotrexate monitoring, HPV vaccination changes, IBS and tricyclic antidepressants , Cognitive screening for fitness to drive, and some brief clinical updates on medication changes. Show notes can be found at https://opotikigp.com/ and My Health Hub https://myhealthhub.co.nz/the-new-zealand-general-practice-podcast/ where you can also watch a video version of the podcast.

Dr Dave teaches Dr Jo about opiate side effects, insulin autoimmune syndrome. more about coffee, urate and cardiovascular risk, MSD extensions, Testosterone in Hypo-Active Sexual Desire Disorder, deprescribing PPIs, Ozempic mouth and measuring flatulence.

Dr Dave this month covers the Sustaining GP Wellbeing toolkit for local GPs in Canterbury, the importance and process of adverse reaction reporting via BPAC, a safety alert about genetic susceptibility to general anaesthetics in patients of Venezuelan maternal origin, permanent changes to Cremation Regulations for deaths in long-term residential or specialist palliative care, new ACC Return to Work Guidelines for elective orthopaedic surgery, the Groov mental wellbeing app, Australian deprescribing guidelines for older people, the updated SPUMS handbook for recreational diving medical assessments, and recent research on gluteus maximus shape predicting type 2 diabetes risk and the gut microbiome’s role in auto-brewery syndrome